Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 5,686 | 21,942 | 2,149 | 2,954 | 421 |
| Gross Profit | 5,686 | 21,942 | 2,149 | 2,954 | 421 |
| Operating Expenses | 11,039 | 19,965 | 9,744 | 11,589 | 12,720 |
| Operating Income | -5,353 | 1,977 | -7,595 | -8,635 | -12,299 |
| Interest Expense | 4 | 109 | 75 | 45 | 128 |
| Other Income | 179 | 217 | 222 | 198 | 170 |
| Pre-tax Income | -5,178 | 2,085 | -7,448 | -8,482 | -12,257 |
| Net Income Continuous | -5,178 | 1,585 | -7,448 | -8,482 | -12,257 |
| Net Income | $-5,178 | $1,585 | $-7,448 | $-8,482 | $-12,257 |
| EPS Basic Total Ops | -1.08 | 1.35 | -2.10 | -2.70 | -4.95 |
| EPS Basic Continuous Ops | -1.08 | 1.40 | -2.22 | -2.67 | -4.95 |
| EPS Diluted Total Ops | -1.08 | 1.35 | -2.10 | -2.70 | -4.95 |
| EPS Diluted Continuous Ops | -1.08 | 1.40 | -2.22 | -2.67 | -4.95 |
| EPS Diluted Before Non-Recurring Items | -1.08 | 0.30 | -2.10 | -2.70 | -5.11 |
| EBITDA(a) | $-4,787 | $2,634 | $-7,687 | $-8,559 | $-12,157 |